Navigation Links
Safe to Stop the Flow?: Differing Attitudes Found Between Women and Doctors Concerning Menstrual Suppression
Date:10/3/2007

Two Thirds of Women Interested in Stopping their Periods, But Unsure About Medical Implications

PHILADELPHIA, Oct. 3 /PRNewswire-USNewswire/ -- More than two thirds of women in a national survey say that they are interested in suppressing their menstrual periods but many of them aren't sure if it's safe. Yet when physicians are polled, 97 percent say that continuous oral contraceptive therapy to suppress menstruation is, in fact, medically safe and acceptable. The survey results were presented by Kurt Barnhart MD, MSCE from the University of Pennsylvania School of Medicine at the Association of Reproductive Health Professionals' (ARHP) Reproductive Health 2007 conference.

"The gap between physician and patient understanding concerning the necessity of monthly periods is obvious," said Dr. Barnhart, Associate Professor and Director of Clinical Research for the Department of Obstetrics & Gynecology. "It is our hope that based on these findings physicians will begin to more readily initiate dialogue with their female patients about continuous therapy -- helping to eliminate the misconception that periods are a medical necessity and to emphasize the safety and viability of menstrual suppression."

Multiple oral contraceptives are already available to reduce menstruation and the FDA recently approved the first continuous oral contraceptive designed to suppress a woman's menstrual cycle. And according to this study, women are increasingly interested in exercising their options. The study found that 63 percent of women reported being extremely or somewhat interested in not having a period. Symptoms cited as the most bothersome aspects of menstruation included cramping, mood swings, bloating and headaches/body aches, while associated personal frustrations cited included avoiding exercise and sexual intercourse, eating more and a decrease in work productivity.

Why would a physician recommend a woman suppress her menses?

"The symptoms
'/>"/>

SOURCE University of Pennsylvania Health System
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Differing reactions to anti clotting drugs may be due to genetic variation.
2. Differing Ideas on Management of Alzheimer’s diseas
3. Risk Attitudes And Consequences Of College Drinking
4. Attitudes About Aging Different from Reality
5. Sexual Attitudes Help Explain Narcissists’ Relationship Problem
6. Men and Women Change Attitudes to Sex When in an Intimate Relationship
7. High-risk Sexual Behavior Adolescents Attract Peers With Similar Attitudes
8. Distraction therapy found very effective in postoperative patients
9. Genetic differences found between Male and Female brains
10. Breastfeeding not found to have an impact on weight of the child.
11. Common Cold Found to Fight Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 4Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 5Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 6Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus 2Health News:Americans United for Life Action Fights the Abortion Bailout by Supporting the Nelson-Hatch-Casey Amendment 2Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 2Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 3
Breaking Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2New FDA Approved Breast Cancer Screening Tool 2New FDA Approved Breast Cancer Screening Tool 3In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug Resistant Influenza Viruses 4981 1In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug Resistant Influenza Viruses 4981 2In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug Resistant Influenza Viruses 4981 3In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug Resistant Influenza Viruses 4981 4Opto electronic nose sniffs out toxic gases 9902 1Opto electronic nose sniffs out toxic gases 9902 2Opto electronic nose sniffs out toxic gases 9902 3Are the monoamines involved in shaping conduct disorders 3F 9898 1Are the monoamines involved in shaping conduct disorders 3F 9898 2Are the monoamines involved in shaping conduct disorders 3F 9898 3Are the monoamines involved in shaping conduct disorders 3F 9898 4Are the monoamines involved in shaping conduct disorders 3F 9898 5Are the monoamines involved in shaping conduct disorders 3F 9898 6